drugset / Trial / NCT02178488

Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers

NCT02178488

Phase 2 Completed 60 enrolled Peter Bergman
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to treat persistent MRSA carriers with vitamin D supplementation during a 12 month to see if the number of MRSA positive patients can be reduced.

Timeline

Start
2014-12
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 4000 iu